Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Long before crystallized bottles showed up in laboratories, alanine already played a quiet but essential role in biology. Scientists like Adolf Strecker figured this out in the 1850s, using rather rudimentary chemistry, and his breakthroughs sparked curiosity about amino acids in general. After the basics emerged, generations of researchers built precise methods for extracting, analyzing, and synthesizing alanine. In the post-war period, as pharmaceutical science matured, a demand for high-purity raw materials put alanine under the microscope—literally. Standards like BP, EP, and USP grew out of this push, defining acceptable qualities for use in medicine. Newer techniques such as chromatography and enzymatic resolution created the modern notion of a pharma grade alanine, showing that lasting discovery comes from a mix of patience, clever ideas, and relentless refinement.
Pharma grade alanine shows up as a white crystalline powder, almost unremarkable to anyone passing through a lab. Tucked in large drums or tiny vials, this ingredient often carries the lifeblood of reliable scientific progress. To qualify as BP, EP, or USP grade, alanine must be above 99.0% purity, with tightly controlled moisture, heavy metals, and related substances. Its clean profile allows it to work as a standard for testing, a buffer component, or even a building block in complex synthesis. In my work, I’ve seen that pharma grade alanine finds its way both into direct treatments and in the machinery of clinical research, soaking up the need for consistency across global supply chains. Pharmacies and factories trust certified lots, relying on clear provenance and traceability that comes only from adhering to these international standards.
Alanine, with the formula C3H7NO2, keeps a low profile among amino acids. It dissolves easily in water, yet avoids dissolution in ether and ethanol, which hints at its practical use in mostly aqueous biological environments. The pKa values hover near 2.34 (the carboxyl group) and 9.69 (the amine group), giving it a zwitterion structure near physiological pH—useful in buffer systems. Melting points for the purest grade climb just above 297°C, and the compound carries a faintly sweet taste. All these metrics may bore outsiders, but they guide pharmacists, helping everybody from process engineers to analytic chemists. In ultrapure forms, alanine appears glassy and uniform, showing no sign of foreign particulates, reflecting not just the cleanliness of the material but also the expertise of its maker.
On arrival, a sealed bag of pharma grade alanine offers more than a name and weight. Labels declare batch number, manufacturing and expiry dates, lot provenance, and compliance stamps matching BP, EP, or USP requirements. Moisture content typically reads below 0.2%, while specific rotation and clarity of solution feature on the certificate of analysis. Residual solvents fall far under established thresholds, guarding against risks that might sneak in from manufacturing. My experience working with these substances taught me not to ignore lot numbers or regulatory symbols—true traceability owes its existence to the right labels, and even a simple oversight in packaging can disrupt pharmacy chains. The details found on every drum and sachet reflect countless regulations crafted over decades, keeping patient safety the true bottom line.
Making alanine on an industrial scale involves more than old-fashioned extraction. Chemists often start with hydrolysis of proteins, breaking down casein or albumin, sifting through the soup to isolate alanine. Synthetic routes take over for pharma grade needs, frequently using the Strecker synthesis—a process that connects simple aldehydes with ammonia and hydrogen cyanide to birth alpha-amino acids. Fermentation offers another route, relying on select bacteria or yeast strains engineered to churn out bulk alanine. Each method demands different controls over temperature, pH, and contaminant screening. It doesn’t suffice to just make alanine; producers push yields and try to minimize impurities, always balancing cost, environmental impact, and downstream quality. Small errors in preparation echo throughout the chain, showing that scale doesn’t erase the need for a careful hand and sharp attention.
Alanine behaves predictably as an amino acid, pitching its amine and carboxyl groups into reactions with acids, bases, and dehydrating agents. Esterification, amidation, and peptide bond formation help chemists build short peptides or complex proteins in test tubes. Protecting group strategies, like Fmoc and Boc, find a place in solid-phase synthesis, letting alanine slip into synthetic peptides that model diseases or screen for new drugs. Racemization—converting L- to D-alanine—raises safety concerns, as different enantiomers impact biological systems in unpredictable ways. Chemists develop rigorous methods to prevent this, knowing that small ratio shifts can transform efficacy or toxicity. I’ve seen quality control labs grind through endless test runs, affirming every detail so that downstream pharmaceutical products meet regulatory needs and keep patients safe from subtle chemical errors.
Alanine doesn't show much variety in common names, unlike more colorful chemicals. Most often, it appears in literature as L-alanine, (S)-2-aminopropanoic acid, or sometimes simply 2-aminopropionic acid. Chemical catalogs stack up synonyms like H-Ala-OH or NSC-22658, but in the pharmaceutical corridors, everything ties back to standards and regulatory language. Language can confuse if not checked—one supplier’s “pharma grade” may differ from another’s unless certificates explicitly confirm BP, EP, or USP compliance. I’ve come to count on the rigorous language that flows through certified documentation: clear names, clear grades, a hundred eyes checking for mistakes before a single vial ends up in research, formulation, or medicine.
In the real world, even a substance hailed as non-toxic must face strict scrutiny not only from regulatory agencies but also from the workers who handle it daily. Handling alanine in bulk calls for gloves, masks, protective eyewear—standard equipment for a professional chemical workplace. Accidental ingestion or inhalation counters the myth that all amino acids are harmless outside the body, as high doses may upset metabolic balances or provoke rare allergic reactions. Industrial guidelines draw a hard line: respect for storage conditions, clear segregation from incompatible substances, and swift reporting of spills or exposure. Regulatory frameworks like those embedded in BP, EP, and USP guide good manufacturing practices, but the wisdom in every safety data sheet only works if workers build long-term habits. Safety culture stands as the last defense for both the purity of the product and the health of everyone on the shop floor.
Alanine may seem unglamorous, but its reach extends across clinical nutrition, parenteral solutions, research, and diagnostics. In hospitals, it enters feed formulations for patients unable to eat, cushioning protein deficits and supporting metabolic functions. Analytical labs use it as an internal standard or for protein sequencing, drawing on stable, predictable behavior. Peptide synthesis, a backbone of drug development, leans on pharma grade alanine for stringent reproducibility. Even beyond the lab and clinic, food regulators silently track its path in fortified products and dietary supplements. Few outside the field realize how many therapies, tests, or formulations would stutter without reliably pure amino acids in the ingredient chain. Every bag and bottle reflects the unseen edges of science, where invisible standards underpin life-saving care.
Research on alanine morphs as the priorities of medicine and science change. Decades ago, studies focused on outlining pathways—how alanine cycles through muscles and the liver, exchanging nitrogen and carbon in the endless shuffle of metabolism. Recent years expanded that knowledge into molecular diagnostics, disease biomarkers, and bioprocessing, where alanine’s metabolic fingerprint helps track disease progression or guide therapy. Intensive work in peptide synthesis, bioengineering, and protein design relies on ever-purer, customizable forms that suit automated synthesis or high-throughput screening. Academics and industry researchers both push for new isolation techniques that reduce waste or boost yields, often driven by sustainability mandates from regulators. I’ve seen industrial labs partner with universities to test green chemistry approaches—a sign that future innovation in such a “basic” compound isn’t slowing down.
Toxicology rarely gives a substance a free pass, even for amino acids found in the human body. Studies repeatedly show that L-alanine, at pharmaceutical doses, carries low acute toxicity in animal and human trials. Overdosing in clinical settings may raise blood levels, with mild effects in healthy subjects, but those with metabolic or renal disorders sometimes face complications if excesses accumulate. Chronic ingestion and occupational exposure data point to limited risk when standards match those set in BP, EP, and USP, but research continues to look for long-term metabolic or allergic consequences. Environmental impact remains modest, as alanine breaks down readily in soil and water. For any new modification—be it a salt, ester, or derivatized peptide—testing resets, confirming that structure tweaks do not shift the safety profile. This research is more than just insurance for regulators; it underpins ethical commitments by companies and universities to public health.
Alanine keeps up with the pace of pharmaceutical science. As medicine moves toward personalized nutrition and precision drug formulations, demand for customized amino acid blends increases. Bio-manufacturing and cell cultivation both seek ultra-pure ingredients, while advances in peptide therapy and diagnostics require larger and more consistent supplies. Climate concerns press manufacturers to shift toward greener synthesis, cutting energy use and hazardous byproducts wherever possible. Improved analytics—like real-time NMR and automated mass spectrometry—let chemists pick up contamination much faster, raising the standard across the entire supply chain. The next few decades will feature a tug-of-war between cost, efficiency, sustainability, and purity, with alanine poised as both a workhorse and bellwether for broader pharmaceutical ingredient standards. Every improvement ripples outward: safer hospitals, better-informed research, and more trustworthy medicine for everyone.
Alanine isn’t one of those hard-to-pronounce chemicals that hide in the small print on supplement bottles. It’s a naturally occurring amino acid, and every person carries it around as part of basic biochemistry. What stands out about pharma grade alanine—marked BP, EP, or USP for British, European, or United States Pharmacopeia standards—comes down to trust. These labels mean purity and safety, not a handful of unknowns. If alanine’s going near medicine or the human body, every particle must meet those rigorous requirements, free from contaminants and consistent in quality.
Take a look at any pharmaceutical lab, and you’ll see a world of checks, balances, and hefty paperwork. There’s a reason for all that caution. Even the smallest impurity in an ingredient like alanine can cause issues, from unpredictable side effects to reduced uptake of a medicine. I’ve seen research where even minor differences in amino acid grade can throw off cell culture experiments or upset the stability of a finished product. Imagine relying on a medicine only to have such surprises. It’s more than frustrating—sometimes it’s dangerous. Pharma grade alanine stops that from happening.
One of the most visible uses of alanine with pharmaceutical credentials happens in clinical nutrition. Hospitals often use amino acid blends as part of intravenous feeding, especially for patients who can’t manage solid food. Alanine fits right in, supplying energy to muscles and supporting recovery. Diabetes care brings up another point: studies show that alanine can help raise blood sugar during hypoglycemic episodes, making it useful for emergency glucose management. It acts fast and predictably thanks to its purity.
Drug makers often use pharma grade alanine in ways most people don’t notice. It acts as a pH buffer or stabilizer, keeping other ingredients from breaking down ahead of time. If you’ve ever opened a medicine bottle and found it just as effective after weeks or months, ingredients like alanine help make that possible. It can also serve as a building block for more complex molecules. Some antibiotics and peptide-based drugs come from starting points like alanine, stringing simple units together to get life-saving treatments.
Every product labeled as BP, EP, or USP alanine faces regular audits, batch testing, and document trails tracking every step from raw material to finished product. This isn’t overkill; mistakes can cause allergic reactions or cross-contamination. People count on medicines to work every time, not just most of the time. I remember an incident early in my career where a compound flunked its quality check, sending the entire project back to square one. The cost in lost work was steep, but it was the right call for patient safety.
Regulators have a tough job, but so do suppliers who provide pharma grade alanine. They have to prove—again and again—that their product stands up to scrutiny. From clinical nutrition to drug formulation, this ingredient’s pharma pedigree keeps it in demand. If the pharma industry slips up at this stage, patients pay the price. That’s why quality standards aren’t a box to check; they’re the line between medicine that helps and medicine that harms.
Meeting the strict standards of pharma grade alanine isn’t just some technical badge—it’s what stands between quality medicine and risk. In familiar labs and pharmaceutical plants, the stuff labeled “BP,” “EP,” or “USP” means it matches or surpasses rules set by top health authorities. These rules don't emerge from thin air. They exist because people can pay a steep price if contamination or impurities slip through.
You might wonder what these standards actually mean day-to-day. For alanine, these benchmarks look past the basic composition and target the bits that could do harm. BP stands for British Pharmacopoeia, EP for European Pharmacopoeia, and USP for United States Pharmacopeia. Their criteria overlap in many ways, but subtle differences reflect the demands and cautions each region serves.
Raw, industrial alanine isn’t suitable for use in healthcare. Factories must push the material through purification lines that strip away reckless amounts of foreign compounds. A typical Pharma Grade lot falls under these targets: purity above 98.5% for the active ingredient, with hardcore limits on heavy metals, related amino acids, and other organics. Each Pharmacopoeia publishes a detailed monograph—a trusted recipe anyone can check.
Take BP and EP. Both require the sample to have no less than 99.0% alanine after drying, which keeps sneaky impurities from inflating results. Water content needs to stay below 0.2% because moisture can mess with shelf life or encourage breakdown. Levels of chloride, sulfate, ammonium, and iron can’t exceed set microgram amounts per gram, reducing the chance of foreign toxicity. USP sets roughly the same bar: at least 98.5% alanine, no more than 0.2% loss on drying, and strict blanketing of other elemental and organic contaminants. Any trace of heavy metals like lead or arsenic must come in far below 10 parts per million, or it can’t go out the door.
Trust in medicine and nutritional therapies depends on what’s inside these bottles. I’ve seen situations in the field where lax ingredient standards meant batches would be rejected, costing everyone—from the manufacturing team to the patient in need. If alanine fails its tests, it can feed the wrong reactions in drugs or trigger side effects that no one wants.
Laboratories don’t rely on a single test. They check physical appearance—crystalline, odorless powder—then use high-performance liquid chromatography (HPLC), spectrophotometry, and elemental analysis to confirm purity. Even just a whisper of benzene or another residual solvent—something folks might say is harmless in trace amounts—counts as too much since repeat exposure piles up in patients over time.
If a supplier can’t show full transparency with Certificates of Analysis (CoA) that name every relevant assay and trace impurity, the risk lands squarely on users. Demand for solid sourcing and documented lab checks lets buyers and patients sleep easier. Independent spot checks and tighter traceability from source to shipment make a difference, too.
When all these safeguards line up, the final product isn’t just another bulk chemical. It’s tightly controlled, clean, and trustworthy—ready for the lives depending on it.
Alanine carries a string of official titles—BP, EP, USP pharma grade. Drug and food companies see those marks as a kind of promise. But a label goes deeper than its gloss. Anyone in pharma or food who’s had a surprise recall knows the importance of what hides beyond the certificate. When I ran compliance in a supplement firm, I learned these grades aren’t just alphabet soup; they map to hard standards set by the British, European, and American pharmacopeias. That means every batch of this amino acid gets held up to rules about purity, how much moisture can cling, and how little heavy metal counts as “trace.”
Here’s where trust and traceability meet. In both the kitchen and the lab, ingredients with pharma or food grade mean fewer headaches—less risk of contaminants fouling the process or the product. Pharma grade means the alanine could appear in tablets and capsules that end up with people who have compromised health. No one wants impurities there. The rules ask for tight testing: assay, optical rotation, microbiological checks. Not every country sticks to those checks with the same energy, though, which places the pressure back on importers and manufacturers who want to avoid disasters like the melamine-tainted milk scandal. I’ve sat through audits where records on raw materials from lesser-known suppliers torched a whole production run.
Walk down the supplement aisle and you’ll see alanine as a building block in protein powders. The shift from strict pharma application to food uses means checking not only purity, but how it behaves with flavorings, stability under heat, or even how it dissolves—a lot more practical than academic. Customers don’t care what code is on the drum; they care if it’s safe to drink after the gym. That’s why food safety authorities, especially in Europe and the US, demand hazard analysis at every step. Even if a grade clears USP, a slip-up in storage, or handling can turn “safe” into “recalled.” It can happen in well-lit warehouses and in less regulated backrooms alike.
There’s a clear reason why pharma grade alanine, if genuine, checks all the boxes for food safety: Pure ingredients with low contamination risks help brands dodge regulatory nightmares. A 2023 survey in the Journal of Food Protection flagged amino acid supplements as sometimes hosting unexpected bacteria, often due to gaps between pharma-grade claims and real storage practices. If you see “pharma grade” on food packaging, trace it back—does the company show transparency on batch certificates and third-party testing?
Even the most impressive certificate means little if the supply chain gets murky. Experienced manufacturers start with questions: Does the supplier have a record of passing audits? Does the alanine batch ride on proper documentation or just on a rubber stamp? I’ve watched firms improve by demanding random lab tests even after receiving supposedly pharma grade ingredients. Backups like this cost extra, but they claw back control. Brands that keep detailed logs from arrival to finished product attract less attention from regulators, and offer peace of mind to cautious buyers.
If you're looking at pharma grade alanine for pills or meal products, focus on supply chain clarity. Transparency, not just trust, guards the line between a top product and an expensive recall. Choosing only certified-grade alanine makes sense, but pulling reports, asking the uneasy questions, and keeping eyes on your paperwork closes the loop in a way no pharma code alone ever will.
Every pharmacist and lab technician knows that even the simplest amino acid, like alanine, can lose its reliability if it’s not stored right. Alanine, classified and produced under BP, EP, or USP pharma-grade standards, plays a crucial role in manufacturing essential medicines and nutritional products. Even a minor drop in purity, triggered by careless storage, can compromise the safety of finished medicines.
Manufacturers stamp a typical shelf life of about two to three years for sealed containers of alanine, assuming the product sits undisturbed in the recommended conditions. Rushing to use up stocks just because the date draws near isn’t the whole story. Real stability comes from both the packaging choice and the place you keep it.
I’ve seen warehouses that ignore the warning signs—leaky windows, sun-exposed shelves, wild temperature swings—and those small oversights eat into product integrity. In real-world practice, storage conditions, not just printed expiry dates, control how long this amino acid stays fit for purpose.
Alanine handles stable storage well, but only if you respect its limits. Temperature matters most: keep containers in a dry, cool space—ideally between 15°C and 30°C (59°F to 86°F). Out-of-range temperatures bring unexpected risks, as accelerated chemical reactions or subtle hydrolysis slowly whittle down purity.
Humidity can sneak through thin packaging and unsettle the powder, leading to clumping and possible degradation. Tightly sealed, airtight containers cut off this threat. I’ve learned the hard way that even brief exposure to damp air can spoil a multi-thousand-dollar batch. If you’ve set up your lab with dehumidifiers or keep stock off the ground and away from windows, your losses drop almost to zero.
Light should never strike the powder directly. Alanine itself doesn’t break down as quickly as some compounds, but broad-spectrum UV exposure always brings risks. Opaque or amber containers solve this with little effort.
No database or barcode can replace a sharp eye and good habits. Pharmacies and manufacturing teams that practice First-In, First-Out (FIFO) consistently avoid mix-ups and keep old stock from lingering past its expiration date. Quick visual inspections—checking for discolored powder, odd smells, or badly sealed lids—should never be rushed.
Every reputable alanine supplier ships lots with certificates of analysis, confirming purity, moisture levels, and microbial loads. These safety nets don’t mean much if you drop the ball on storage. Studies published in pharmaceutical journals have shown that temperatures climbing above 40°C or containers left unsealed can trigger losses in purity, and in some cases, invite the growth of unwanted microbes.
Anyone handling pharma-grade alanine should regularly review safety protocols. Train staff to spot early signs of degradation. Designate secure areas in storage rooms with documented temperature and humidity logs. Simple steps, like closing containers immediately after use and keeping storage areas clean, pay high returns in both safety and cost avoidance.
In pharmaceutical work, no amount of fancy packaging or certificates can replace diligent people. Alanine can stay stable for years—if you give it a steady home and knowledgeable hands.
If you’ve ever spent time in a product development lab or handled pharmaceutical ingredients, you know how important it is to trust what’s in the bottle. Customers and regulators want proof. This is where a Certificate of Analysis, better known as a COA, plays a key role. With something as widely used as Alanine BP EP USP Pharma Grade, the demand for reliability goes beyond just ticking compliance boxes. Patients, pharmacists, chemists, and regulatory officers all have a stake in getting things right.
Every pharmaceutical ingredient has to meet certain standards before it gets to the shelf. Alanine, labeled with BP, EP, and USP marks, points to British, European, and United States Pharmacopeia standards. Without testing—and without a clear, transparent record—manufacturers and buyers are left in the dark. A COA provides a factual summary of the batch, presenting data such as purity level, impurity profile, heavy metals testing, pH, loss on drying, and microbial results when applicable.
Having a COA attached gives everyone in the supply chain peace of mind. A document signed by someone who takes responsibility for the results stands as proof. Pharmacies, clinics, and healthcare manufacturers depend on these batch-to-batch results because the smallest difference in purity or contamination can raise red flags, delay work, or even risk patient safety. Reputable vendors never hesitate to include a COA, because trust and safety stay at the core of their business.
Alanine may seem straightforward—just another amino acid supplement or lab reagent. In reality, its high grade means it could end up in sensitive formulations, from IV solutions to nutritional blends. Scrutiny only grows with increasing regulatory alerts and recalls involving subpar raw materials. For end users, a missing COA invites tough questions from quality control and procurement teams, and sometimes causes a shipment rejection.
Industry guidelines set by organizations like the FDA and EMA require documented validation for every ingredient. A batch without matching paperwork signals potential trouble to anyone performing an audit. Supply contracts frequently specify that no delivery can take place without supporting documents. This trend grew out of years of lessons—ingredients without a traceable record have led to dosage failures, systemic recalls, and bad outcomes for both patients and companies.
Not all COAs are created equal. It’s easy to think any slip of paper showing a value is enough, but quality teams know better. Look for the manufacturer, batch number, date of analysis, reference to BP/EP/USP monographs, and a signature. Results should be matched to pharmacopeia acceptance criteria. Gaps or vague values should prompt questions—no responsible supplier shies away from explaining their results.
Some suppliers may try to deliver Alanine as a generic chemical without documentation. In years of working with pharmaceutical teams, I’ve seen orders paused and contracts cancelled because supporting paperwork wasn’t in place. On the flip side, companies that take documentation seriously build better relationships and avoid regulatory headaches down the road.
Stronger quality agreements make a difference. Buyers should write clear terms into contracts: no COA, no acceptance. Suppliers should invest in training and validation, and make COAs available before shipping. Digital tracking adds transparency and makes audits easier to handle. For buyers unsure about a batch, a third-party test never hurts. A trustworthy supply chain doesn’t just follow the rules—it proves every step along the way, right down to that final document handed over with each shipment of Alanine.
| Names | |
| Preferred IUPAC name | 2-aminopropanoic acid |
| Other names |
Ala 2-Aminopropanoic acid L-Alanine DL-Alanine α-Aminopropionic acid |
| Pronunciation | /ˈæləˌniːn biː piː iː piː juː ɛs piː ˈfɑːmə ɡreɪd/ |
| Identifiers | |
| CAS Number | 56-41-7 |
| Beilstein Reference | 74-89-5 |
| ChEBI | CHEBI:16977 |
| ChEMBL | CHEMBL1069 |
| ChemSpider | 602 |
| DrugBank | DB00160 |
| ECHA InfoCard | 03bfa414-8d18-4950-a8ef-9f0a0abfa116 |
| EC Number | 200-273-8 |
| Gmelin Reference | 607104 |
| KEGG | C00041 |
| MeSH | D01.268.479.199.044.150 |
| PubChem CID | 5950 |
| RTECS number | AY2992000 |
| UNII | N4Z6660USQ |
| UN number | UN1230 |
| Properties | |
| Chemical formula | C3H7NO2 |
| Molar mass | 89.09 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.424 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -2.85 |
| Acidity (pKa) | 2.35 |
| Basicity (pKb) | 10.24 |
| Viscosity | 1 cP (20°C) |
| Dipole moment | 1.80 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 86.0 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -433.4 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1507 kJ/mol |
| Pharmacology | |
| ATC code | A16AA05 |
| Hazards | |
| Main hazards | Not a hazardous substance or mixture. |
| GHS labelling | GHS labelling: Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. |
| Pictograms | GHS07 |
| Signal word | Non-hazardous |
| Hazard statements | No hazard statements. |
| Precautionary statements | Precautionary Statements: P261, P305+P351+P338 |
| NFPA 704 (fire diamond) | 1-0-0 |
| LD50 (median dose) | LD50 (median dose): >5000 mg/kg (Oral, Rat) |
| PEL (Permissible) | PEL (Permissible) of Alanine BP EP USP Pharma Grade: Not established |
| REL (Recommended) | 20 - 40 mg |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
2-Aminoisobutyric acid Beta-Alanine Serine Valine |
Chengguan District, Lanzhou, Gansu, China
